Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984 Aug;18(2):250–253. doi: 10.1111/j.1365-2125.1984.tb02464.x

Antipyrine absorption after delayed oesophageal capsule transit.

K S Channer, C J Roberts
PMCID: PMC1463519  PMID: 6487466

Abstract

Twenty fasted patients were given hard gelatin capsules containing antipyrine and barium, and in ten patients the capsule arrested and disintegrated in the oesophagus. Plasma antipyrine was assayed at 10 min intervals for 1 h, then 30 min intervals for a further 3 h. The plasma concentration-time curves for the patients in whom the capsule entered the stomach rapidly, and for those in whom the capsule lodged in the oesophagus, were compared. The absorption in the first hour was calculated from the area under the plasma concentration-time curve and found to be significantly lower if the capsule disintegrated in the oesophagus (P less than 0.0005). The time to peak plasma concentration was delayed by an average of 46 min (P less than 0.01) and the peak plasma concentration was significantly lower (P less than 0.05) if delayed capsule transit occurred. Delayed capsule transit through the oesophagus significantly changed the pharmacokinetic profile of antipyrine.

Full text

PDF
250

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Channer K. S., Virjee J. Effect of posture and drink volume on the swallowing of capsules. Br Med J (Clin Res Ed) 1982 Dec 11;285(6356):1702–1702. doi: 10.1136/bmj.285.6356.1702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Collins F. J., Matthews H. R., Baker S. E., Strakova J. M. Drug-induced oesophageal injury. Br Med J. 1979 Jun 23;1(6179):1673–1676. doi: 10.1136/bmj.1.6179.1673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Danhof M., Groot-van der Vis E., Breiner D. D. Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man. Pharmacology. 1979;18(4):210–223. doi: 10.1159/000137254. [DOI] [PubMed] [Google Scholar]
  4. Fisher R. S., Malmud L. S., Applegate G., Rock E., Lorber S. H. Effect of bolus composition on esophageal transit: concise communication. J Nucl Med. 1982 Oct;23(10):878–882. [PubMed] [Google Scholar]
  5. Hey H., Jørgensen F., Sørensen K., Hasselbalch H., Wamberg T. Oesophageal transit of six commonly used tablets and capsules. Br Med J (Clin Res Ed) 1982 Dec 11;285(6356):1717–1719. doi: 10.1136/bmj.285.6356.1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Stevenson I. H. Factors influencing antipyrine elimination. Br J Clin Pharmacol. 1977 Jun;4(3):261–265. doi: 10.1111/j.1365-2125.1977.tb00710.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES